US Stock MarketDetailed Quotes

ALPMY Astellas Pharma (ADR)

Watchlist
  • 9.680
  • 0.0000.00%
15min DelayTrading Jan 7 09:38 ET
17.33BMarket Cap50.16P/E (TTM)

Astellas Pharma (ADR) Key Stats

Astellas Pharma (ADR) Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 414.065B--
Feb 4, 20252025/Q3-- / 448.790B--
Oct 30, 20242025/Q2462.497B / 425.282B--
Aug 1, 20242025/Q1473.124B / 411.415B--
Apr 25, 20242024/Q4414.602B / 381.093B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 414.065B--
Feb 4, 20252025/Q3-- / 448.790B--
Oct 30, 20242025/Q2462.497B / 425.282B--
Aug 1, 20242025/Q1473.124B / 411.415B--
Apr 25, 20242024/Q4414.602B / 381.093B--

Unlock Free Earnings Estimates

Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.